Insights on the Contraceptives Global Market to 2028 - Increasing Awareness About Sexually Transmitted Diseases Presents Opportunities
30 juil. 2021 09h13 HE
|
Research and Markets
Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "Contraceptives Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, End User, Distribution Channel" report has been added to...
Global Non-hormonal Therapies for Women's Health Market Report 2021-2030: Current Market Landscape with Focus on Prescription Drugs & Future Potential of this Evolving Market
20 juil. 2021 04h18 HE
|
Research and Markets
Dublin, July 20, 2021 (GLOBE NEWSWIRE) -- The "Non-hormonal Therapies for Women's Health Market by Target Indication, Type of Molecule, Purpose of Therapy, Mechanism of Action, Route of...
Agile Therapeutics Announces Presentation of Safety and Efficacy Data of Twirla® (Levonorgestrel and Ethinyl Estradiol) Transdermal System in Women of Differing BMI Categories at ACOG Annual Meeting
30 avr. 2021 11h01 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that a post hoc analysis of the Phase 3 SECURE Trial...
New UNFPA data reveals that nearly 12 million women lost access to contraception due to disruptions caused by the pandemic, leading to 1.4 million unintended pregnancies
11 mars 2021 00h05 HE
|
UNFPA
New York, March 11, 2021 (GLOBE NEWSWIRE) -- UNFPA, the UN sexual and reproductive health agency, releases new data today indicating that nearly 12 million women in 115 countries lost access to...
Agile Therapeutics Reports Fourth Quarter & Full Year 2020 Financial Results; Expands Loan Facility With Perceptive Advisors
01 mars 2021 16h05 HE
|
Agile Therapeutics, Inc.
Perceptive Advisors Increases Credit Facility to $45 million, with $25 million potentially available Achieved Gross Revenue Target In Fourth Quarter 2020, Reflecting Initial Stocking of Twirla®...
Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Monday, March 1, 2021
19 févr. 2021 08h35 HE
|
Agile Therapeutics, Inc.
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will...
U.S. Supreme Court Upholds Trump Administration’s Exemptions to Contraceptive Mandate
08 juil. 2020 12h46 HE
|
First Liberty Institute
WASHINGTON, July 08, 2020 (GLOBE NEWSWIRE) -- The Supreme Court of the United States today held 7–2 in Little Sisters of the Poor. v. Pennsylvania, et al., that the Trump Administration has the...
Religious Liberty Firm to Supreme Court: End this Assault on Little Sisters of the Poor, Religious Organizations
10 mars 2020 09h59 HE
|
First Liberty Institute
WASHINGTON, March 10, 2020 (GLOBE NEWSWIRE) -- First Liberty Institute filed a friend-of-the-court brief in Little Sisters of the Poor v. Pennsylvania urging the Supreme Court of the United States...
Researchers at Queen’s University Belfast have Developed a Vaginal Ring Capable of Providing Sustained Delivery of OB-002 (5P12-RANTES) for HIV Prevention
12 févr. 2019 09h00 HE
|
Orion Biotechnology Canada Ltd
OTTAWA, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that researchers at the School of Pharmacy, Queen’s University...
Offer youth intrauterine methods of contraception first, paediatricians advise
31 mai 2018 00h01 HE
|
Canadian Paediatric Society
OTTAWA, May 31, 2018 (GLOBE NEWSWIRE) -- Intrauterine methods of contraception should be the first-line birth control option for youth, according to a new position statement from the Canadian...